Sorry, you need to enable JavaScript to visit this website.

A Phase 3 Study of Tanezumab for Chronic Low Back Pain (TANGO)

A Phase 3 Randomized, Double-Blind, Placebo and Active-Controlled, Multicenter, Parallel-Group Study of
the Analgesic Efficacy and Safety of Tanezumab in Adult Subjects With Chronic Low Back Pain

Category & Conditions: Neurological Diseases and Conditions
Medicine: tanezumab Identifier (NCT): NCT02528253
Protocol ID: A4091059
Open Plain Language Summary Result: Click here